Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02685631 · ClinicalTrials.gov registry record
Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study
A clinical trial, sponsored by Vanderbilt-Ingram Cancer Center.
- Completed
- Registry status
- 1,653
- Enrollment target
NCT02685631: Completed study, sponsored by Vanderbilt-Ingram Cancer Center.
NCT02685631 is a clinical trial that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 1,653 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02685631 has completed, sponsored by Vanderbilt-Ingram Cancer Center.
- COMPLETED
- Registry status
- 1,653 participants
- Enrollment target
Study Summary
This research registry studies Yttrium Y 90 resin microspheres in collecting data from patients with liver cancer not capable of being removed by surgery (unresectable) for the radiation-emitting Selective Internal Radiation-Spheres (SIR-spheres) in non-resectable (RESIN) liver tumor registry. The information generated will help doctors better understand treatment patterns involving Y90 therapy, gain additional insights in the long-term outcomes for patients, as well as guide future research for using Y90 therapy, especially for those conditions where data is currently very limited or lacking.
Primary Outcome
Response to treatment is the initial measure of treatment efficacy. This can be measured using objective criteria such as the modified Response Evaluation Criteria in Solid Tumors (mRECIST) or European Association for Study of Liver Cancer (EASL) criteria depending on local policy and tumor type.
Interventions
- OTHER Yttrium-90 Resin Microspheres
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,653 participants |
| Start Date | 2015-07 |
| Est. Completion | 2021-08-31 |
What the finished NCT02685631 record still lists
NCT02685631 is an observational study that tracks outcomes without assigning an intervention. Its 1,653 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Yttrium-90 Resin Microspheres is the first listed.
NCT02685631 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02685631 about?
NCT02685631 is a clinical study titled "Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study". This research registry studies Yttrium Y 90 resin microspheres in collecting data from patients with liver cancer not capable of being removed by surgery (unresectable) for the radiation-emitting Selective Internal Radiation-Spheres (SIR-spheres) in non-resectable (RESIN) liver tumor registry. The i...
What is the current status of trial NCT02685631?
This trial is currently completed. The enrollment target is 1,653 participants. The study started on 2015-07. Estimated completion is 2021-08-31.
What interventions are being tested in trial NCT02685631?
The interventions under investigation include: Yttrium-90 Resin Microspheres (OTHER).
Who is sponsoring clinical trial NCT02685631?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06401330 · 1,656 participants · Phase 3
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
- NCT04510129 · 1,650 participants
A Multicenter Cancer Biospecimen Collection Study
- NCT05612750 · 1,650 participants · NA
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
- NCT06215716 · 1,650 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia